TET protein inhibitors: Potential and limitations

Kaplánek, R; Kejík, Z; Hajduch, J; Veselá, K; Kucnirová, K; Skalicková, M; Venhauerová, A; Hosnedlová, B; Hromádka, R; Dytrych, P; Novotny, P; Abramenko, N; Antonyová, V; Hoskovec, D; Babula, P; Masarík, M; Martásek, P; Jakubek, M

Jakubek, M (通讯作者)，Charles Univ Prague, Fac Med 1, BIOCEV, Prumyslova 595, Vestec 25250, Czech Republic.;Martásek, P (通讯作者)，Charles Univ Prague, Fac Med 1, Dept Paediat & Inherited Metab Disorders, Ke Karlovu 455-2, Prague 12808, Czech Republic.;Martásek, P (通讯作者)，Gen Univ Hosp Prague, Ke Karlovu 455-2, Prague 12808, Czech Republic.

BIOMEDICINE & PHARMACOTHERAPY, 2023; 166 ():

Abstract

TET proteins (methylcytosine dioxygenases) play an important role in the regulation of gene expression. Dysregulation of their activity is associated ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索